期刊文献+

阿斯匹林、氯吡格雷、噻氯匹定预防缺血性脑卒中临床观察 被引量:2

下载PDF
导出
摘要 目的:比较阿斯匹林、氯吡格雷、噻氯匹定对缺血性脑卒中患者再发生缺血事件的影响。急性脑梗塞患者223例。方法:阿斯林组(88例),阿斯匹林肠溶75—100mg/日。氯吡格雷组(63例75mg/日)。噻氯匹定组(72例),主要终点指示为再次缺血性卒中或短暂性脑缺血发作(TIA)。结果:阿斯匹林组(79.55%)。氯吡格雷组缺血性卒中或TIA发生率(82.54%)。噻氯匹定组(77.78%),三组统计学比较无差异,(P〉0.05)。结论:阿斯匹林、氯吡格雷、噻氯匹定预防缺血事件再发的效果无显著差异。
出处 《中国中医药咨讯》 2010年第35期135-135,共1页
  • 相关文献

参考文献2

二级参考文献7

  • 1Antithrombotic Trialists′ Collaboration.Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death,myocardial infarction,and stroke in high risk patients.BMJ,2002,324:71-86.
  • 2Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events.The SALT Collaborative Group.Lancet,1991,338:1345-1349.
  • 3European Stroke Prevention Study 2.Efficacy and safety data.J Neurol Sci,1997,151 Suppl:S1-S77.
  • 4Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke.EAFT (European Atrial Fibrillation Trial) Study Group.Lancet,1993,342:1255-1262.
  • 5Ridker PM,Cook NR,Lee IM,et al.A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.N Engl J Med,2005,352:1293-1304.
  • 6The International Stroke Trial (IST):a randomised trial of aspirin,subcutaneous heparin,both,or neither among 19435 patients with acute ischaemic stroke.International Stroke Trial Collaborative Group.Lancet,1997,349:1569-1581.
  • 7CAST:randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke.CAST (Chinese Acute Stroke Trial) Collaborative Group.Lancet,1997,349:1641-1649.

共引文献75

同被引文献15

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部